Open AccessS694 Comparative Efficacy and Safety of Ozanimod vs Adalimumab and Vedolizumab in Patients with Moderately to Severely Active Ulcerative Colitis
Author(s) -
Marla Dubinsky,
Keith A. Betts,
Kenneth LaPensee,
Devrim Eren,
Dawn Kim-Romo,
Lei Yin,
Wenxi Tang,
Komal Gupte-Singh
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000776308.71765.85
Subject(s) - medicine , ulcerative colitis , adalimumab , vedolizumab , placebo , dermatology , surgery , tumor necrosis factor alpha , disease , pathology , alternative medicine